Early Investor Books Gains After $32 Mn Funding Round Led by OrbiMed
Early-stage investment platform Venture Catalysts has announced its full exit from women’s hygiene brand Pee Safe following the company’s recent $32 million funding round led by OrbiMed. The exit was facilitated through the secondary component of the round, which provided liquidity to early investors.
Venture Catalysts had first invested in Pee Safe in 2017, backing the company at an early stage as it expanded from a toilet hygiene-focused product into a broader personal hygiene and wellness brand.
Strong Returns Highlight Early-Stage Investment Strategy
The exit, completed in January 2026, generated a 9.6x multiple on invested capital and an XIRR of 30.53% for Venture Catalysts and its limited partners. The outcome reflects the firm’s strategy of identifying high-potential startups early and supporting them through scale and market expansion.
Pee Safe has grown significantly over the years through an omnichannel distribution model, with products available across more than 50,000 offline retail outlets in over 100 cities, along with e-commerce and quick commerce platforms.
Growth Momentum in Women’s Hygiene and Wellness Segment
The company has recorded consistent growth of around 45–50% annually over the past two years, driven by increasing awareness and demand for women’s hygiene products in India.
Venture Catalysts said it will continue to invest in consumer, healthcare, and technology startups with strong fundamentals and clear paths to liquidity, focusing on early-stage opportunities where capital and ecosystem support can accelerate long-term value creation.
Keep building. Keep learning. Keep growing with StartupByDoc.